$SRPT Company News 7 gut checks before the stock
Post# of 44845
Posted On: 01/17/2014 2:17:58 PM
$SRPT Company News
7 gut checks before the stock market's opening bell 7:54 a.m. July 25, 2013 - Shawn Langlois
7 gut checks before the stock market's opening bell 8:00 a.m. July 24, 2013 - Shawn Langlois
Sarepta up 21% on plans to submit drug application 6:55 a.m. July 24, 2013 - Sara Sjolin
Ignore your feelings, obey the market 12:15 p.m. July 23, 2013 - The Trading Deck
For stock speculators, it’s down to two choices 11:10 a.m. June 27, 2013 - The Trading Deck
5 stocks insiders are betting on 11:15 a.m. June 25, 2013 - Insider Monkey
How to get the Nasdaq out of neutral 2:11 p.m. June 18, 2013 - The Trading Deck
Tuesday’s movers: Apple snaps 3-day losing streak 4:09 p.m. April 16, 2013 - Sue Chang
The market that can do no wrong? 10:14 a.m. March 26, 2013 - The Trading Deck
6 stocks positioning for breakouts 8:53 a.m. March 15, 2013 - The Trading Deck
3 speculative names for a market stuck in neutral 8:49 a.m. March 14, 2013 - The Trading Deck
Caesars, Zynga among charts to watch today 1:50 p.m. Feb. 28, 2013 - The Trading Deck
13 stocks for ’13 6:16 p.m. Jan. 3, 2013 - The Trading Deck
Dow, Nasdaq return to scene of the breakdown 12:02 p.m. Nov. 27, 2012 - Michael Ashbaugh
Dow, Nasdaq return to scene of the breakdown 11:46 a.m. Nov. 27, 2012 - Michael Ashbaugh
Charting the S&P 500’s precarious position 12:20 p.m. Nov. 13, 2012 - Michael Ashbaugh
Charting the S&P 500’s precarious position 11:46 a.m. Nov. 13, 2012 - Michael Ashbaugh
Charting the Election Day backdrop 12:09 p.m. Nov. 6, 2012 - Michael Ashbaugh
Charting the Election Day backdrop 11:34 a.m. Nov. 6, 2012 - Michael Ashbaugh
Nasdaq retesting the 200-day moving average 11:10 a.m. Oct. 25, 2012 - Michael Ashbaugh
My Five Favorite Bio-Pharma Stocks from the J.P. Morgan Healthcare Conference 27 min ago - TheStreet.com
Perilous Reversal Stock: Sarepta Therapeutics (SRPT) 9:47 a.m. Today - TheStreet.com
Sarepta Therapeutics (SRPT) Soars: Stock Up 40.1% - Tale of the Tape 9:39 a.m. Today - Zacks.com
SRPT February 14th Options Begin Trading 11:19 a.m. Jan. 16, 2014 - TheStreet.com
Sarepta surges following results for Eteplirsen therapy 9:00 a.m. Jan. 16, 2014 - Seeking Alpha
SRPT Stock – Sarepta Shares Up on Muscular Dystrophy Drug Success 3:23 a.m. Jan. 16, 2014 - InvestorPlace.com
Sarepta Therapeutics' CEO Presents at 32nd Annual J.P. Morgan Healthcare Conference (Transcript) 11:31 p.m. Jan. 15, 2014 - Seeking Alpha
Sarepta releases 120 week eteplirsen data 4:22 p.m. Jan. 15, 2014 - Seeking Alpha
J.P. Morgan Healthcare Confab Live Blog: Day Three 10:12 a.m. Jan. 15, 2014 - TheStreet.com
5 Biotech Stocks With Big Catalysts on the Horizon 3:26 a.m. Jan. 15, 2014 - InvestorPlace.com
It's Lunchtime at the J.P. Morgan Healthcare Confab. Here's What I Learned So Far 4:12 p.m. Jan. 13, 2014 - TheStreet.com
Short Interest In Sarepta Therapeutics Makes 15% Move 3:10 p.m. Jan. 13, 2014 - TheStreet.com
Sarepta names Art Krieg as CSO 4:31 p.m. Jan. 9, 2014 - Seeking Alpha
The Twitterverse's Biotech Stock Picks for 2014 8:00 a.m. Jan. 7, 2014 - TheStreet.com
Sarepta claws back losses, FDA letter offers sliver of hope on early review 12:54 p.m. Jan. 6, 2014 - Seeking Alpha
This FDA Letter About Sarepta and Accelerated Approval for Eteplirsen Will Blow Your Mind 12:37 p.m. Jan. 6, 2014 - TheStreet.com
UPDATE: Sarepta Downgraded by Citigroup on Eteplirsen Early Approval Setback 10:25 a.m. Jan. 6, 2014 - benzinga.com
Citi negative on Sarepta, Ariad for 2014, shares slide 8:21 a.m. Jan. 6, 2014 - Seeking Alpha
On the Road to Riches in Biotech 4:10 a.m. Dec. 28, 2013 - Barrons.com
Eteplirsen's Competitive Advantage Is Setting Up Sarepta For 2014 7:57 a.m. Dec. 25, 2013 - Seeking Alpha
Sarepta Therapeutics Announces Eteplirsen Demonstrates Continued Stability on Walking Test through 120 Weeks in Phase IIb Study in Duchenne Muscular Dystrophy 4:05 p.m. Jan. 15, 2014 - BusinessWire - BZX
Critical Alerts For Ford, Clovis Oncology, Johnson Controls, Juniper Networks, and Sarepta Therapeutics Released By InvestorsObserver 9:31 a.m. Jan. 14, 2014 - PR Newswire - PRF
Sarepta Therapeutics Names Art Krieg, M.D., Chief Scientific Officer 4:04 p.m. Jan. 9, 2014 - BusinessWire
Notable Buzzers: Twitter Inc, Sarepta Therapeutics Inc, SolarCity Corp, General Electric Company 10:31 a.m. Jan. 6, 2014 - ACCESSWIRE
Biotech Industry Stock Update: Cell Therapeutics, Sarepta Therapeutics, ACADIA Pharma, and Medivation 8:00 a.m. Jan. 2, 2014 - PR Newswire
Morning Buzz: Twitter Inc, Sarepta Therapeutics, Buka Ventures, Bison Petroleum Corp 10:31 a.m. Dec. 23, 2013 - ACCESSWIRE
Sarepta Therapeutics to Present Company Overview at the 2014 32nd Annual J.P. Morgan Healthcare Conference 8:30 a.m. Dec. 19, 2013 - Marketwire
Critical Alerts For Johnson and Johnson, Express Scripts, Sarepta Therapeutics, Xilinx, and Universal Display Corp Released By InvestorsObserver 9:31 a.m. Dec. 13, 2013 - PR Newswire
Hot Stocks Radar: Sarepta Therapeutics, Synta Pharmaceuticals, Lululemon Athletica, Inc, Canadian Solar Inc 11:12 a.m. Dec. 12, 2013 - ACCESSWIRE
The Ten Biggest Medical Successes of 2013 8:30 a.m. Dec. 11, 2013 - PR Newswire
Breakfast Technical Briefing: Sarepta Therapeutics, ACADIA Pharma, Cell Therapeutics, and Medivation 11:23 a.m. Dec. 6, 2013 - PR Newswire
Sarepta Therapeutics to Present Company Overview at Upcoming Conferences 8:30 a.m. Nov. 19, 2013 - Marketwire
Levi & Korsinsky, LLP Launches Investigation of SAREPTA THERAPEUTICS, INC. for Possible Violations of Federal Securities Laws 2:58 p.m. Nov. 13, 2013 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT 12:03 p.m. Nov. 13, 2013 - PR Newswire
Insider Trading Research for Micron, Hertz, Annaly Capital Management, Sarepta Therapeutics, Rackspace Hosting, and Tesla Motors 8:55 a.m. Nov. 13, 2013 - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Sarepta Therapeutics, Inc. 3:00 p.m. Nov. 12, 2013 - PR Newswire
SRPT, HOLX, QUIK and VNDA added to NASDAQ Active Stock Watch List at GSR 10:21 a.m. Nov. 12, 2013 - ACCESSWIRE
Sarepta Therapeutics Announces Third Quarter 2013 Financial Results and Recent Corporate Developments 7:01 a.m. Nov. 12, 2013 - Marketwire
Critical Alerts For Micron Technology, Sarepta Therapeutics, Alliance Fiber Optic Products, Pfizer, and KB Home Released By InvestorsObserver 9:31 a.m. Nov. 11, 2013 - PR Newswire
Morning Research: Medivation Inc., ACADIA Pharma Inc., Sarepta Therapeutics Inc., and Cell Therapeutics Inc. 8:00 a.m. Nov. 11, 2013 - PR Newswire
7 gut checks before the stock market's opening bell 7:54 a.m. July 25, 2013 - Shawn Langlois
7 gut checks before the stock market's opening bell 8:00 a.m. July 24, 2013 - Shawn Langlois
Sarepta up 21% on plans to submit drug application 6:55 a.m. July 24, 2013 - Sara Sjolin
Ignore your feelings, obey the market 12:15 p.m. July 23, 2013 - The Trading Deck
For stock speculators, it’s down to two choices 11:10 a.m. June 27, 2013 - The Trading Deck
5 stocks insiders are betting on 11:15 a.m. June 25, 2013 - Insider Monkey
How to get the Nasdaq out of neutral 2:11 p.m. June 18, 2013 - The Trading Deck
Tuesday’s movers: Apple snaps 3-day losing streak 4:09 p.m. April 16, 2013 - Sue Chang
The market that can do no wrong? 10:14 a.m. March 26, 2013 - The Trading Deck
6 stocks positioning for breakouts 8:53 a.m. March 15, 2013 - The Trading Deck
3 speculative names for a market stuck in neutral 8:49 a.m. March 14, 2013 - The Trading Deck
Caesars, Zynga among charts to watch today 1:50 p.m. Feb. 28, 2013 - The Trading Deck
13 stocks for ’13 6:16 p.m. Jan. 3, 2013 - The Trading Deck
Dow, Nasdaq return to scene of the breakdown 12:02 p.m. Nov. 27, 2012 - Michael Ashbaugh
Dow, Nasdaq return to scene of the breakdown 11:46 a.m. Nov. 27, 2012 - Michael Ashbaugh
Charting the S&P 500’s precarious position 12:20 p.m. Nov. 13, 2012 - Michael Ashbaugh
Charting the S&P 500’s precarious position 11:46 a.m. Nov. 13, 2012 - Michael Ashbaugh
Charting the Election Day backdrop 12:09 p.m. Nov. 6, 2012 - Michael Ashbaugh
Charting the Election Day backdrop 11:34 a.m. Nov. 6, 2012 - Michael Ashbaugh
Nasdaq retesting the 200-day moving average 11:10 a.m. Oct. 25, 2012 - Michael Ashbaugh
My Five Favorite Bio-Pharma Stocks from the J.P. Morgan Healthcare Conference 27 min ago - TheStreet.com
Perilous Reversal Stock: Sarepta Therapeutics (SRPT) 9:47 a.m. Today - TheStreet.com
Sarepta Therapeutics (SRPT) Soars: Stock Up 40.1% - Tale of the Tape 9:39 a.m. Today - Zacks.com
SRPT February 14th Options Begin Trading 11:19 a.m. Jan. 16, 2014 - TheStreet.com
Sarepta surges following results for Eteplirsen therapy 9:00 a.m. Jan. 16, 2014 - Seeking Alpha
SRPT Stock – Sarepta Shares Up on Muscular Dystrophy Drug Success 3:23 a.m. Jan. 16, 2014 - InvestorPlace.com
Sarepta Therapeutics' CEO Presents at 32nd Annual J.P. Morgan Healthcare Conference (Transcript) 11:31 p.m. Jan. 15, 2014 - Seeking Alpha
Sarepta releases 120 week eteplirsen data 4:22 p.m. Jan. 15, 2014 - Seeking Alpha
J.P. Morgan Healthcare Confab Live Blog: Day Three 10:12 a.m. Jan. 15, 2014 - TheStreet.com
5 Biotech Stocks With Big Catalysts on the Horizon 3:26 a.m. Jan. 15, 2014 - InvestorPlace.com
It's Lunchtime at the J.P. Morgan Healthcare Confab. Here's What I Learned So Far 4:12 p.m. Jan. 13, 2014 - TheStreet.com
Short Interest In Sarepta Therapeutics Makes 15% Move 3:10 p.m. Jan. 13, 2014 - TheStreet.com
Sarepta names Art Krieg as CSO 4:31 p.m. Jan. 9, 2014 - Seeking Alpha
The Twitterverse's Biotech Stock Picks for 2014 8:00 a.m. Jan. 7, 2014 - TheStreet.com
Sarepta claws back losses, FDA letter offers sliver of hope on early review 12:54 p.m. Jan. 6, 2014 - Seeking Alpha
This FDA Letter About Sarepta and Accelerated Approval for Eteplirsen Will Blow Your Mind 12:37 p.m. Jan. 6, 2014 - TheStreet.com
UPDATE: Sarepta Downgraded by Citigroup on Eteplirsen Early Approval Setback 10:25 a.m. Jan. 6, 2014 - benzinga.com
Citi negative on Sarepta, Ariad for 2014, shares slide 8:21 a.m. Jan. 6, 2014 - Seeking Alpha
On the Road to Riches in Biotech 4:10 a.m. Dec. 28, 2013 - Barrons.com
Eteplirsen's Competitive Advantage Is Setting Up Sarepta For 2014 7:57 a.m. Dec. 25, 2013 - Seeking Alpha
Sarepta Therapeutics Announces Eteplirsen Demonstrates Continued Stability on Walking Test through 120 Weeks in Phase IIb Study in Duchenne Muscular Dystrophy 4:05 p.m. Jan. 15, 2014 - BusinessWire - BZX
Critical Alerts For Ford, Clovis Oncology, Johnson Controls, Juniper Networks, and Sarepta Therapeutics Released By InvestorsObserver 9:31 a.m. Jan. 14, 2014 - PR Newswire - PRF
Sarepta Therapeutics Names Art Krieg, M.D., Chief Scientific Officer 4:04 p.m. Jan. 9, 2014 - BusinessWire
Notable Buzzers: Twitter Inc, Sarepta Therapeutics Inc, SolarCity Corp, General Electric Company 10:31 a.m. Jan. 6, 2014 - ACCESSWIRE
Biotech Industry Stock Update: Cell Therapeutics, Sarepta Therapeutics, ACADIA Pharma, and Medivation 8:00 a.m. Jan. 2, 2014 - PR Newswire
Morning Buzz: Twitter Inc, Sarepta Therapeutics, Buka Ventures, Bison Petroleum Corp 10:31 a.m. Dec. 23, 2013 - ACCESSWIRE
Sarepta Therapeutics to Present Company Overview at the 2014 32nd Annual J.P. Morgan Healthcare Conference 8:30 a.m. Dec. 19, 2013 - Marketwire
Critical Alerts For Johnson and Johnson, Express Scripts, Sarepta Therapeutics, Xilinx, and Universal Display Corp Released By InvestorsObserver 9:31 a.m. Dec. 13, 2013 - PR Newswire
Hot Stocks Radar: Sarepta Therapeutics, Synta Pharmaceuticals, Lululemon Athletica, Inc, Canadian Solar Inc 11:12 a.m. Dec. 12, 2013 - ACCESSWIRE
The Ten Biggest Medical Successes of 2013 8:30 a.m. Dec. 11, 2013 - PR Newswire
Breakfast Technical Briefing: Sarepta Therapeutics, ACADIA Pharma, Cell Therapeutics, and Medivation 11:23 a.m. Dec. 6, 2013 - PR Newswire
Sarepta Therapeutics to Present Company Overview at Upcoming Conferences 8:30 a.m. Nov. 19, 2013 - Marketwire
Levi & Korsinsky, LLP Launches Investigation of SAREPTA THERAPEUTICS, INC. for Possible Violations of Federal Securities Laws 2:58 p.m. Nov. 13, 2013 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT 12:03 p.m. Nov. 13, 2013 - PR Newswire
Insider Trading Research for Micron, Hertz, Annaly Capital Management, Sarepta Therapeutics, Rackspace Hosting, and Tesla Motors 8:55 a.m. Nov. 13, 2013 - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Sarepta Therapeutics, Inc. 3:00 p.m. Nov. 12, 2013 - PR Newswire
SRPT, HOLX, QUIK and VNDA added to NASDAQ Active Stock Watch List at GSR 10:21 a.m. Nov. 12, 2013 - ACCESSWIRE
Sarepta Therapeutics Announces Third Quarter 2013 Financial Results and Recent Corporate Developments 7:01 a.m. Nov. 12, 2013 - Marketwire
Critical Alerts For Micron Technology, Sarepta Therapeutics, Alliance Fiber Optic Products, Pfizer, and KB Home Released By InvestorsObserver 9:31 a.m. Nov. 11, 2013 - PR Newswire
Morning Research: Medivation Inc., ACADIA Pharma Inc., Sarepta Therapeutics Inc., and Cell Therapeutics Inc. 8:00 a.m. Nov. 11, 2013 - PR Newswire
(0)
(0)Scroll down for more posts ▼